Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Hashimoto

Showing results (71-80 of 861) with videos related to

Pageof 87
Sort By:
Progress in Brain Research|July 6, 2023
Neuroinflammation through the vagus nerve-dependent gut-microbiota-brain axis in treatment-resistant depressionKenji Hashimoto
Eclinicalmedicine|January 11, 2020
Impact of age on optimal dose of antidepressantsKenji Hashimoto
Frontiers in Pharmacology|February 15, 2019
Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological DisordersKenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience|June 4, 2020
Risk of neuropsychiatric disorders in offspring of COVID-19-infected pregnant women and nutritional interventionKenji Hashimoto
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 3, 2006
[Depression and BDNF]Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience|August 29, 2019
Mood, psychomotor, and cognitive function in major depressive disorder: from biomarkers to rapid-acting antidepressantsKenji Hashimoto
Annals of Neurology|March 19, 2011
Can minocycline prevent the onset of Alzheimer's disease?Kenji Hashimoto
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 26, 2008
Microglial activation in schizophrenia and minocycline treatmentKenji Hashimoto
Psychiatry and Clinical Neurosciences|July 27, 2010
Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directionsKenji Hashimoto
Expert Review of Neurotherapeutics|December 21, 2012
Understanding depression: linking brain-derived neurotrophic factor, transglutaminase 2 and serotoninKenji Hashimoto
Pageof 87

Showing results (71-80 of 861) with videos related to

Sort By:
Pageof 87
Progress in Brain Research|July 6, 2023
Neuroinflammation through the vagus nerve-dependent gut-microbiota-brain axis in treatment-resistant depressionKenji Hashimoto
Eclinicalmedicine|January 11, 2020
Impact of age on optimal dose of antidepressantsKenji Hashimoto
Frontiers in Pharmacology|February 15, 2019
Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological DisordersKenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience|June 4, 2020
Risk of neuropsychiatric disorders in offspring of COVID-19-infected pregnant women and nutritional interventionKenji Hashimoto
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 3, 2006
[Depression and BDNF]Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience|August 29, 2019
Mood, psychomotor, and cognitive function in major depressive disorder: from biomarkers to rapid-acting antidepressantsKenji Hashimoto
Annals of Neurology|March 19, 2011
Can minocycline prevent the onset of Alzheimer's disease?Kenji Hashimoto
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 26, 2008
Microglial activation in schizophrenia and minocycline treatmentKenji Hashimoto
Psychiatry and Clinical Neurosciences|July 27, 2010
Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directionsKenji Hashimoto
Expert Review of Neurotherapeutics|December 21, 2012
Understanding depression: linking brain-derived neurotrophic factor, transglutaminase 2 and serotoninKenji Hashimoto
Pageof 87